BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35130345)

  • 1. 4-1BBL-containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells.
    Swatler J; Turos-Korgul L; Brewinska-Olchowik M; De Biasi S; Dudka W; Le BV; Kominek A; Cyranowski S; Pilanc P; Mohammadi E; Cysewski D; Kozlowska E; Grabowska-Pyrzewicz W; Wojda U; Basak G; Mieczkowski J; Skorski T; Cossarizza A; Piwocka K
    Blood Adv; 2022 Mar; 6(6):1879-1894. PubMed ID: 35130345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
    Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
    Front Immunol; 2018; 9():1274. PubMed ID: 29922294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients.
    Govindaraj C; Madondo M; Kong YY; Tan P; Wei A; Plebanski M
    Am J Hematol; 2014 Aug; 89(8):795-802. PubMed ID: 24757092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.
    Qu Y; Wang X; Bai S; Niu L; Zhao G; Yao Y; Li B; Li H
    Int J Cancer; 2022 Apr; 150(8):1373-1391. PubMed ID: 34766338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients.
    Govindaraj C; Tan P; Walker P; Wei A; Spencer A; Plebanski M
    Clin Cancer Res; 2014 Feb; 20(3):724-35. PubMed ID: 24297862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD30
    Lam JH; Hong M; Koo SL; Chua CWL; Lim KL; Wee F; Wan WK; Leow WQ; Yeo JG; Tan IBH; Yeong J; Lim TKH; Lim TS
    Cancer Immunol Immunother; 2021 Aug; 70(8):2353-2365. PubMed ID: 33527196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia.
    Goral A; Firczuk M; Fidyt K; Sledz M; Simoncello F; Siudakowska K; Pagano G; Moussay E; Paggetti J; Nowakowska P; Gobessi S; Barankiewicz J; Salomon-Perzynski A; Benvenuti F; Efremov DG; Juszczynski P; Lech-Maranda E; Muchowicz A
    Front Immunol; 2022; 13():781364. PubMed ID: 35296093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myeloid leukemia-derived extracellular vesicles increase Foxp3 level and suppressive activity of thymic regulatory T cells.
    Swatler J; Dudka W; Bugajski L; Brewinska-Olchowik M; Kozlowska E; Piwocka K
    Eur J Immunol; 2020 Apr; 50(4):606-609. PubMed ID: 31758697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Significance of Tumor Necrosis Factor Receptor Type II in CD8
    Ye LL; Wei XS; Zhang M; Niu YR; Zhou Q
    Front Immunol; 2018; 9():583. PubMed ID: 29623079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.
    Chen X; Bäumel M; Männel DN; Howard OM; Oppenheim JJ
    J Immunol; 2007 Jul; 179(1):154-61. PubMed ID: 17579033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis.
    Kim S; Maeng JY; Hyun SJ; Sohn HJ; Kim SY; Hong CH; Kim TG
    Theranostics; 2020; 10(11):5011-5028. PubMed ID: 32308765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells.
    Chen X; Hamano R; Subleski JJ; Hurwitz AA; Howard OM; Oppenheim JJ
    J Immunol; 2010 Jul; 185(1):174-82. PubMed ID: 20525892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity.
    Chen Y; Jia M; Wang S; Xu S; He N
    Front Immunol; 2022; 13():835690. PubMed ID: 35251028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias.
    Swatler J; Turos-Korgul L; Kozlowska E; Piwocka K
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model.
    Wang R; Feng W; Wang H; Wang L; Yang X; Yang F; Zhang Y; Liu X; Zhang D; Ren Q; Feng X; Zheng G
    Cancer Lett; 2020 Jan; 469():151-161. PubMed ID: 31669202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SA-4-1BBL costimulation inhibits conversion of conventional CD4+ T cells into CD4+ FoxP3+ T regulatory cells by production of IFN-γ.
    Madireddi S; Schabowsky RH; Srivastava AK; Sharma RK; Yolcu ES; Shirwan H
    PLoS One; 2012; 7(8):e42459. PubMed ID: 22870329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4
    Ghods A; Mehdipour F; Shariat M; Talei AR; Ghaderi A
    Mol Immunol; 2021 Sep; 137():52-56. PubMed ID: 34214829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of TNFR2-expressing regulatory T cells in malignant pleural effusion of lung cancer patients is associated with poor prognosis.
    Ye LL; Peng WB; Niu YR; Xiang X; Wei XS; Wang ZH; Wang X; Zhang SY; Chen X; Zhou Q
    Ann Transl Med; 2020 Dec; 8(24):1647. PubMed ID: 33490159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.
    Chen X; Subleski JJ; Kopf H; Howard OM; Männel DN; Oppenheim JJ
    J Immunol; 2008 May; 180(10):6467-71. PubMed ID: 18453563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.
    Kampan NC; Madondo MT; McNally OM; Stephens AN; Quinn MA; Plebanski M
    Front Immunol; 2017; 8():1482. PubMed ID: 29163543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.